公式財務諸表に基づく売上高、利益、キャッシュフローの推移。
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments.
インタラクティブチャートと全財務諸表を見る → バリュエーションモデル（DCF）→
| 損益計算書 | TTM → 2026-03-31 | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 | 2017-09-30 | 2016-09-30 | 2015-09-30 | 2014-09-30 | 2013-09-30 | 2012-09-30 | 2011-09-30 | 2010-09-30 | 2009-09-30 | 2008-09-30 | 2007-09-30 | 2006-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 売上高合計 | $21.4B | $21.8B | $20.2B | $19.4B | $18.9B | $19.1B | $16.1B | $17.3B | $16.0B | $12.1B | $12.5B | $10.3B | $8.4B | $8.1B | $7.7B | $7.6B | $7.1B | $7.0B | $7.1B | $6.4B | $5.7B |
| 売上総利益 | $9.9B | $9.9B | $9.1B | $8.2B | $8.5B | $8.6B | $6.8B | $8.3B | $7.3B | $6.0B | $6.0B | $4.7B | $4.3B | $4.2B | $4.0B | $4.0B | $3.7B | $3.7B | $3.6B | $3.3B | $2.9B |
| 売上総利益率 % | 46.5% | 45.4% | 45.2% | 42.2% | 44.9% | 45.1% | 42.3% | 47.9% | 45.5% | 49.3% | 48.0% | 45.7% | 50.9% | 51.8% | 51.3% | 52.2% | 51.9% | 52.6% | 51.3% | 51.7% | 51.3% |
| 営業利益（EBIT） | $2.3B | $2.6B | $2.4B | $2.1B | $2.3B | $2.2B | $912M | $1.8B | $1.5B | $1.5B | $1.4B | $1.1B | $1.6B | $1.3B | $1.6B | $1.7B | $1.6B | $1.6B | $1.5B | $1.2B | $1.1B |
| 営業利益率 % | 10.6% | 11.8% | 11.9% | 10.9% | 12.1% | 11.8% | 5.7% | 10.2% | 9.4% | 12.6% | 11.5% | 10.4% | 19.0% | 15.6% | 20.2% | 22.0% | 22.2% | 22.8% | 21.7% | 18.9% | 19.9% |
| 当期純利益 | $1.1B | $1.7B | $1.7B | $1.5B | $1.8B | $2.1B | $874M | $1.2B | $311M | $1.1B | $976M | $695M | $1.2B | $1.3B | $1.2B | $1.3B | $1.3B | $1.2B | $1.1B | $890M | $752M |
| 純利益率 % | 5.3% | 7.7% | 8.5% | 7.7% | 9.4% | 10.9% | 5.4% | 7.1% | 1.9% | 9.1% | 7.8% | 6.8% | 14.0% | 16.1% | 15.2% | 16.8% | 18.5% | 17.6% | 15.9% | 14.0% | 13.1% |
| EBITDA | $4.7B | $5.0B | $4.8B | $4.4B | $4.4B | $4.4B | $3.1B | $4.1B | $3.9B | $2.6B | $2.6B | $2.0B | $2.2B | $1.8B | $2.1B | $2.2B | $2.1B | $2.1B | $2.1B | $1.8B | $1.6B |
| 1株当たり利益（EPS） | $3.94 | $5.84 | $5.86 | $5.15 | $6.19 | $7.16 | $3.09 | $4.49 | $1.18 | $4.92 | $4.49 | $3.35 | $5.99 | $6.49 | $5.59 | $5.62 | $5.49 | $4.99 | $4.46 | $3.49 | $2.93 |
| 発行済株式数（百万株） | 281M | 287M | 291M | 288M | 287M | 292M | 282M | 275M | 265M | 224M | 218M | 208M | 198M | 199M | 209M | 226M | 240M | 247M | 253M | 255M | 257M |
出典: 企業の公開資料（SEC）。数値をご利用の前に SEC EDGAR でご確認ください。
貸借対照表、キャッシュフロー計算書、四半期データおよび全財務比率は BDX のインタラクティブ・ビューアーでご覧いただけます。 /companies/us/BDX
本サイトの情報は教育および情報提供のみを目的としており、投資助言ではありません。目標株価や投資判断は掲載していません。
About TickerBase · Data methodology & sources · Privacy · Terms